INTERFACE INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data INTERFACE INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	959	996	1,180	1,343	1,103	1,200	1,298	1,261	1,316	1,387
Cost of revenue	590	610	750	810	693	768	860	820	833	849
Gross profit	369	386	430	533	411	433	438	441	483	537
Research and development	14.3	14	16.4	17.8	18.6	19.3	19.1	17	15.1	16.1
Selling, general and administrative	262	267	333	389	333	324	324	339	349	373
Operating income	87.2	112	76.4	131	-39.3	105	75.4	105	134	164
Interest expense	6.13	7.13	15.4	25.7	29.2	29.7	29.9	31.8	23.2	19.5
Other non-operating income	-1.89	-3.9	-5.95	-3.43	-10.9	-2.48	-3.55	-9.08	2.35	-7.6
Pre-tax income	79.1	101	55	102	-79.4	72.6	41.9	63.7	114	137
Income tax	25	47.3	4.74	22.6	-7.49	17.4	22.4	19.1	26.6	20.8
Net income	54.2	53.2	50.3	79.2	-71.9	55.2	19.6	44.5	86.9	116
EBITDA	118	142	115	176	6.63	151	116	145	174	203
EPS, basic	0.83	0.86	0.84	1.34	-1.23	0.94	0.33	0.77	1.49	1.99
EPS, diluted	0.83	0.86	0.84	1.34	-1.23	0.94	0.33	0.76	1.48	1.96
Shares, basic (weighted)	65.1	62	59.5	58.9	58.5	59	58.9	58.1	58.3	58.4
Shares, diluted (weighted)	65.1	62	59.6	58.9	58.5	59	58.9	58.3	58.9	59.2
Dividend per share	0.22	0.25	0.26	0.26	0.10	0.04	0.04	0.04	0.04	0.06

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	166	87	81	81.3	103	97.3	97.6	110	99.2	71.3
Short-term investments	0	0	0	0	0	0	0	0	0	0
Receivables	126	143	179	177	140	172	183	163	171	174
Inventory	156	178	259	254	229	265	306	279	261	275
Other current assets	23.1	23.1	40.2	35.8	23.7	38.3	30.3	30.9	33.4	34
Total current assets	471	431	559	548	495	572	617	584	564	555
Property, plant and equipment	205	213	293	325	359	330	298	291	282	309
Lease right-of-use assets			0	107	98	90.6	81.6	87.5	76.8	78.2
Goodwill	61.2	68.8	246	257	166	147	102	105	99.9	112
Intangible assets				29.7	27.3	76.2	59.8	56.3	48.3	50.9
Other non-current assets	65.7	70.3	73.7	77.1	81.9	90.2	89.9	84.2	74.5	75.8
Total assets	835	801	1,285	1,423	1,306	1,330	1,267	1,230	1,171	1,207
Accounts payable	45.4	50.7	66.3	75.7	58.7	85.9	78.3	62.9	68.9	64.8
Accrued liabilities	98.7	111	126	141	106	146	120	131	135	148
Short-term debt	15	15	31.3	31	15.3	15	10.2	8.57	0.48	8.78
Total current liabilities	159	177	224	263	193	262	220	215	217	237
Long-term debt	255	215	587	565	561	503	510	409	302	173
Lease liabilities			0	91.8	86.5	77.9	72.3	78.3	68.1	67.2
Other non-current liabilities	75.6	72	92.6	99	104	87.2	63.5	68.7	62.8	65.4
Total liabilities	495	471	930	1,055	979	967	905	804	682	566
Total debt	270	230	619	596	577	518	520	417	303	182
Paid-in capital	359	271	270	250	248	253	244	253	261	249
Retained earnings	140	187	222	286	209	261	279	321	405	518
Shareholders' equity	341	330	355	368	327	363	362	426	489	641
Total equity	341	330	355	368	327	363	362	426	489	641
Total liabilities and equity	835	801	1,285	1,423	1,306	1,330	1,267	1,230	1,171	1,207
Shares outstanding				58.4	58.7	59.1	58.1	58.1	58.3	57.9

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	54.2	53.2	50.3	79.2	-71.9	55.2	19.6	44.5	86.9	116
Depreciation and amortization	30.6	30.3	39.1	44.9	45.9	46.3	40.3	40.8	39.3	38.9
Stock-based compensation					-0.5	5.47	8.53	10.3	12.9	14.4
Deferred income tax	3.52	23.7	-8.89	-2.62	0.13	-7.38	-1.48	-6.88	-4.45	-12.5
Change in receivables	-0.37	-10.3	-10.1	-0.93	40.1	-36.1	-17.5	21.8	-13.9	4.62
Change in inventory	2.69	-13.6	-18.8	2.57	38.7	-47.1	-49.7	31	10.5	2.1
Change in payables	12.2	12	9.94	19.4	-60.9	74.2	-24.2	-6.44	18.2	1.91
Cash from operations	98.1	103	91.8	142	119	86.7	43.1	142	148	168
Capital expenditures	-28.1	-30.5	-54.9	-74.6	-62.9	-28.1	-18.4	-26.1	-33.8	-46.2
Acquisitions	0	0	-401	0	0
Cash from investing	-26.4	-31.1	-456	-74.2	-61.7	-28.1	-18.4	-19.5	-30.4	-46.2
Debt repaid	0							0	0	-300
Stock issued	0	0	0.29	0.06	0.09	0	0
Share buybacks	-18.5	-91.6	-14.5	-25.2	0	0	-17.2	0	0	-18.2
Dividends paid	-14.3	-15.5	-15.5	-15.4	-5.57	-2.36	-2.36	-2.32	-2.34	-3.56
Cash from financing	19.6	-157	362	-66.7	-42.7	-60.9	-19.5	-112	-125	-159
Exchange rate effect	-1.3	6.08	-3.66	-0.56	7.09	-3.56	-4.82	1.98	-4.09	9.68
Net change in cash	90	-78.6	-6.05	0.31	21.8	-5.8	0.31	12.9	-11.3	-27.9
Free cash flow	70	72.9	36.9	67.1	56.1	58.6	24.6	116	115	122
Interest paid	5.5	6.3	13.8	22.7	32	22.9	25.1	28.8	22.8	18
Income taxes paid	12.8	19.1	29.5	34.8	19.3	23.1	31.4	25.8	37.8	37.3

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 5, 2026; growth uses fiscal years. Valuation uses the share price of $35.20 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	40.5%	Gross profit / revenue.
Operating margin	13.6%	Operating income / revenue.
EBITDA margin	16.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	12.2%	Pre-tax income / revenue.
Net margin	10.1%	Net income / revenue.
FCF margin	8.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	12.4%	Cash from operations / revenue.
Effective tax rate	17.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	21.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	11.5%	Net income / average total assets.
Return on invested capital (ROIC)	20.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	26.9%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.2%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.7%	Capital expenditures / revenue.
D&A / revenue	2.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	5.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	2.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	4.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	11.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	7.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	5.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	22.0%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	29.6%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	16.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	20.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	98.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	33.5%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	81.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	32.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	81.1%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	13.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	57.4%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	7.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	6.2%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	70.3%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	16.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	50.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	14.5%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	-8.8%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	31.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	21.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	14.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	3.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-1.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-1.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.53x	Current assets / current liabilities.
Quick ratio	1.18x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.33x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.30x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	16.1%	Total debt / total assets.
Liabilities / assets	46.6%	Total liabilities / total assets.
Net debt	$122.8M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.52x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	12.5x	Operating income / interest expense.
Working capital	$378.1M	Current assets - current liabilities.
Goodwill and intangibles / assets	3.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$629.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.13x	Revenue / average total assets.
Fixed asset turnover	4.60x	Revenue / average property, plant and equipment.
Inventory turnover	2.94x	Cost of revenue / average inventory.
Days inventory	124 days	365 x average inventory / cost of revenue.
Receivables turnover	6.86x	Revenue / average receivables.
Days sales outstanding	53 days	365 x average receivables / revenue.
Days payables	37 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	140 days	Days inventory + days sales outstanding - days payables.
FCF conversion	85.2%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	30.3%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.50	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$24.71	Revenue / diluted weighted shares.
FCF per share	$2.13	Free cash flow / diluted weighted shares.
Operating cash flow per share	$3.05	Cash from operations / diluted weighted shares.
Book value per share	$11.74	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$10.88	Tangible book value / shares outstanding.
Cash per share	$1.41	(Cash + short-term investments) / shares outstanding.
Payout ratio	4.1%	Dividends paid / net income, when net income is positive.
Dividends / FCF	4.8%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	28.0%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$2.03B	Share price x shares outstanding.
Enterprise value	$2.16B	Market cap + total debt - cash - short-term investments.
P/E	14.0x	Market cap / net income. Only when net income is positive.
P/S	1.41x	Market cap / revenue.
P/B	3.00x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.23x	Market cap / tangible book value, when positive.
P/FCF	16.4x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	11.4x	Market cap / cash from operations, when positive.
EV/Sales	1.50x	Enterprise value / revenue.
EV/EBIT	11.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	9.16x	Enterprise value / EBITDA, when both are positive.
EV/FCF	17.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	6.1%	Free cash flow / market cap.
Earnings yield	7.2%	Net income / market cap (the inverse of P/E).
Dividend yield	0.3%	Dividends paid over the period / market cap.
Shareholder yield	2.0%	(Dividends paid + share buybacks) / market cap.
PEG	0.17x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was INTERFACE INC's revenue in fiscal 2025?

INTERFACE INC reported revenue of $1.39B for fiscal 2025, 5.4% higher than the year before.

Was INTERFACE INC profitable in fiscal 2025?

Yes. Net income was $116.1M, a net margin of 8.4%.

How much free cash flow did INTERFACE INC generate in fiscal 2025?

Cash from operations of $167.9M minus capital expenditures of $46.2M left free cash flow of $121.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to INTERFACE INC